| Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial DR Holmes, S Kar, MJ Price, B Whisenant, H Sievert, SK Doshi, K Huber, ... Journal of the American College of Cardiology 64 (1), 1-12, 2014 | 1870 | 2014 |
| Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial MJ Price, PB Berger, PS Teirstein, JF Tanguay, DJ Angiolillo, D Spriggs, ... Jama 305 (11), 1097-1105, 2011 | 1618 | 2011 |
| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ... Journal of the American College of Cardiology 56 (12), 919-933, 2010 | 1356 | 2010 |
| 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials VY Reddy, SK Doshi, S Kar, DN Gibson, MJ Price, K Huber, RP Horton, ... Journal of the American College of Cardiology 70 (24), 2964-2975, 2017 | 943 | 2017 |
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... Journal of the American College of Cardiology 62 (24), 2261-2273, 2013 | 926 | 2013 |
| Effect of platelet inhibition with cangrelor during PCI on ischemic events DL Bhatt, GW Stone, KW Mahaffey, CM Gibson, PG Steg, CW Hamm, ... New England Journal of Medicine 368 (14), 1303-1313, 2013 | 905 | 2013 |
| Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk P Urban, R Mehran, R Colleran, DJ Angiolillo, RA Byrne, D Capodanno, ... Circulation 140 (3), 240-261, 2019 | 899 | 2019 |
| Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation MJ Price, S Endemann, RR Gollapudi, R Valencia, CT Stinis, JP Levisay, ... European heart journal 29 (8), 992-1000, 2008 | 788 | 2008 |
| Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis DR Holmes, SK Doshi, S Kar, MJ Price, JM Sanchez, H Sievert, ... Journal of the American College of Cardiology 65 (24), 2614-2623, 2015 | 621 | 2015 |
| Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial DJ Angiolillo, MS Firstenberg, MJ Price, PE Tummala, M Hutyra, IJ Welsby, ... Jama 307 (3), 265-274, 2012 | 557 | 2012 |
| Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay … MJ Price, DJ Angiolillo, PS Teirstein, E Lillie, SV Manoukian, PB Berger, ... Circulation 124 (10), 1132-1137, 2011 | 511 | 2011 |
| American heart association council on E, prevention statistics c, stroke statistics s. heart disease and stroke statistics-2019 update: a report from the American heart association EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ... Circulation 139 (10), e56-e528, 2019 | 510 | 2019 |
| Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: a collaborative meta-analysis of individual participant data SS Brar, J Ten Berg, R Marcucci, MJ Price, M Valgimigli, HS Kim, G Patti, ... Journal of the American College of Cardiology 58 (19), 1945-1954, 2011 | 510 | 2011 |
| Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary … D Sibbing, D Aradi, D Alexopoulos, J Ten Berg, DL Bhatt, L Bonello, ... JACC: Cardiovascular Interventions 12 (16), 1521-1537, 2019 | 466 | 2019 |
| Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary … D Aradi, A Kirtane, L Bonello, PA Gurbel, US Tantry, K Huber, ... European heart journal 36 (27), 1762-1771, 2015 | 404 | 2015 |
| Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective–2018 … DJ Angiolillo, SG Goodman, DL Bhatt, JW Eikelboom, MJ Price, ... Circulation 138 (5), 527-536, 2018 | 403 | 2018 |
| International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies DJ Angiolillo, F Rollini, RF Storey, DL Bhatt, S James, DJ Schneider, ... Circulation 136 (20), 1955-1975, 2017 | 402 | 2017 |
| The role of presence in virtual reality exposure therapy M Price, P Anderson Journal of anxiety disorders 21 (5), 742-751, 2007 | 299 | 2007 |
| Intravascular lithotripsy for treatment of severely calcified coronary artery disease JM Hill, DJ Kereiakes, RA Shlofmitz, AJ Klein, RF Riley, MJ Price, ... Journal of the American College of Cardiology 76 (22), 2635-2646, 2020 | 288 | 2020 |
| The NCDR left atrial appendage occlusion registry JV Freeman, P Varosy, MJ Price, D Slotwiner, FM Kusumoto, ... Journal of the American College of Cardiology 75 (13), 1503-1518, 2020 | 287 | 2020 |
